BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+0.5%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.7B
AUM Growth
-$152M
(-1.5%)
Cap. Flow
+$254M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
29.73%
Holding
233
New
14
Increased
60
Reduced
64
Closed
42
Top Buys
| 1 |
CareDx
CDNA
|
$65.3M |
| 2 |
Abbott
ABT
|
$50.4M |
| 3 |
Molina Healthcare
MOH
|
$46.5M |
| 4 |
Danaher
DHR
|
$44.5M |
| 5 |
Medtronic
MDT
|
$34M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$63.1M |
| 2 |
Centene
CNC
|
$40.7M |
| 3 |
Baxter International
BAX
|
$40.6M |
| 4 |
Hologic
HOLX
|
$22.3M |
| 5 |
DexCom
DXCM
|
$15.4M |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Technology | 0.8% |
| 3 | Industrials | 0.75% |
| 4 | Communication Services | 0.02% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Becton Dickinson
BDX
$54.8B
| $115M | 1.18% |
466,797
-164
| -0% | -$40.2K |
|
27
Jazz Pharmaceuticals
JAZZ
$7.76B
| $113M | 1.16% |
886,854
+117,616
| +15% | +$15M |
|
28
Stryker
SYK
$151B
| $113M | 1.16% |
421,884
-448
| -0.1% | -$120K |
|
|
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
| $105M | 1.08% |
1,872,014
+263,220
| +16% | +$14.7M |
|
30
Insulet
PODD
$24.4B
| $102M | 1.05% |
382,723
-271
| -0.1% | -$72.1K |
|
|
31
Molina Healthcare
MOH
$9.25B
| $100M | 1.03% |
314,582
+146,327
| +87% | +$46.5M |
|
32
Inspire Medical Systems
INSP
$2.56B
| $96.8M | 1% |
420,780
-278
| -0.1% | -$64K |
|
33
Align Technology
ALGN
$9.76B
| $96.3M | 0.99% |
146,564
-10,467
| -7% | -$6.88M |
|
|
MYOV
34
DELISTED
Myovant Sciences Ltd.
MYOV
| $96.1M | 0.99% |
6,169,039
+400,000
| +7% | +$6.23M |
|
35
Insmed
INSM
$30.1B
| $95.9M | 0.99% |
3,520,861
+135,216
| +4% | +$3.68M |
|
36
Revolution Medicines
RVMD
$7.29B
| $87.3M | 0.9% |
3,470,162
+11,357
| +0.3% | +$286K |
|
37
Option Care Health
OPCH
$4.67B
| $83.2M | 0.86% |
2,924,043
+328,229
| +13% | +$9.33M |
|
38
Kezar Life Sciences
KZR
$27.9M
| $82.2M | 0.85% |
491,815
+38,500
| +8% | +$6.44M |
|
|
AMED
39
DELISTED
Amedisys
AMED
| $79.3M | 0.82% |
490,012
+187,214
| +62% | +$30.3M |
|
40
Idexx Laboratories
IDXX
$51.2B
| $77.7M | 0.8% |
117,979
-141
| -0.1% | -$92.8K |
|
|
SWAV
41
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $76.1M | 0.78% |
426,610
-37,637
| -8% | -$6.71M |
|
42
HCA Healthcare
HCA
$96.4B
| $75.6M | 0.78% |
294,434
-47,039
| -14% | -$12.1M |
|
|
VCRA
43
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $75.3M | 0.78% |
1,160,613
+6,572
| +0.6% | +$426K |
|
44
Sarepta Therapeutics
SRPT
$1.93B
| $74.4M | 0.77% |
826,741
+257,573
| +45% | +$23.2M |
|
45
CRISPR Therapeutics
CRSP
$4.8B
| $73.9M | 0.76% |
974,684
| – | – |
|
46
Evolent Health
EVH
$1.1B
| $72.2M | 0.74% |
2,609,293
-423,385
| -14% | -$11.7M |
|
|
ACCD
47
DELISTED
Accolade, Inc. Common Stock
ACCD
| $71.7M | 0.74% |
2,721,375
+861,172
| +46% | +$22.7M |
|
48
ESSA Pharma
EPIX
$11.1M
| $71.5M | 0.74% |
5,034,814
| – | – |
|
|
49
Medtronic
MDT
$119B
| $69M | 0.71% |
667,408
+328,283
| +97% | +$34M |
|
|
50
CareDx
CDNA
$697M
| $66.7M | 0.69% |
1,466,552
+1,435,609
| +4,640% | +$65.3M |
|